Cardiol Therapeutics Inc. (NASDAQ:CRDL) Receives $8.67 Consensus Price Target from Brokerages
Shares of Cardiol Therapeutics Inc. (NASDAQ:CRDL – Get Free Report) have been assigned an average rating of “Buy” from the five ratings firms that are covering the stock, MarketBeat.com reports. Three investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12 […]
Shares of Cardiol Therapeutics Inc. (NASDAQ:CRDL – Get Free Report) have been assigned an average rating of “Buy” from the five ratings firms that are covering the stock, MarketBeat.com reports. Three investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12 […]
